Comparing the anti-remodeling effect of sacubitril/valsartan and angiotensin-converting enzyme inhibition on myocardial samples of advanced heart failure patients undergoing heart transplantation

Back

ESC Professional Premium Access

Comparing the anti-remodeling effect of sacubitril/valsartan and angiotensin-converting enzyme inhibition on myocardial samples of advanced heart failure patients undergoing heart transplantation

Session: Experiments in cardiac hypertrophy, atrophy, and remodelling

Topic: Ventricular Remodelling

Speaker: Doctor D. Nagy (Budapest, HU)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor David Nagy

Budapest (Hungary)

0 follower

6 more presentations in this session

Titin hyper-phosphorylation in the peripheral skeletal muscle but not the diaphragm of HFpEF: association with muscle atrophy and dysfunction.

Speaker: Mrs B. Vahle (Dresden, DE)

HECT domain containing-3 (HECTD3) E3 ubiquitin ligase attenuates cardiac ischemia and hypertrophy in mice

Speaker: Doctor A. Deshpande (Heidelberg, DE)

Relationships between 18-month kinetics and functional capacity and left ventricular remodeling and cardiac fibrosis in dilated cardiomyopathy

Speaker: Doctor S. Wisniowska-Smialek (Krakow, PL)

The transcription factor foxo3 regulates cardiac remodeling after myocardial infarction

Speaker: Professor C. Skurk (Berlin, DE)

Gradual hypertensive response in aortic alterations and myocardial inflammatory activation in progressing HFpEF in mice

Speaker: Mrs D. Torma (Kuopio, FI)

Access the full session

Experiments in cardiac hypertrophy, atrophy, and remodelling

Speakers: Doctor D. Nagy, Mrs B. Vahle, Doctor A. Deshpande, Doctor S. Wisniowska-Smialek, Professor C. Skurk...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources